2nd Targeted Intracellular Delivery Summit

Leveraging Cellular and Molecular Biology to Improve Uptake and Specificity of Your Drug for Maximal Therapeutic Effect

Time: 9:00 AM – 5:00 PM

Venue Details: Hilton Boston Logan Airport, One Hotel Dr, Boston, Massachusetts, 02128, United States

Prices:
Academic Pricing – Conference + Workshop Day: USD 4197.00,
Academic Pricing – Conference Only: USD 2999.00,
Drug Developer Pricing – Conference + Workshop Day: USD 5097.00,
Drug Developer Pricing – Conference Only: USD 3699.00,
Service Provider Pricing – Conference + Workshop Day: USD 3597.00,
Service Provider Pricing – Conference Only: USD 2599.00

Speakers: Marie McAvoy, Chief Scientific Officer, NanoSyrinx, Shraddha Sharma, Head of In Vitro Biology and Mechanism of Action, Sanofi, Jagesh Shah, Vice President of Gene Therapy and Technologies, Sana Biotechnology, Stephen Kasper, Associate Principal Scientist, Merck and Co, Aric Frantz, Senior Director Pharmacology and Toxicology, Capstan Therapeutics, Christopher Locher, Chief Executive Officer, Versatope Therapeutics, Antonietta Impagliazzo, Director of Future Technologies, Genmab, David Guay, Vice President Innovation and Technology, Feldan Therapeutics, James Ferguson, Chief Medical Officer, Matinas BioPharma, Rajesh Shukla, Senior Medical Director, SSI Strategy, Kyle Trudeau, Senior Director, Gene Therapy Research, Sana Biotechnology, Ravit Uzan, Project Manager, Biond Biologics, Paul Lawrence, Executive Director of Research and Discovery, Biocogent, Kalina Paunovska, Co-founder, Nava Therapeutics, Roman Melnyk, Associate Professor and Senior Scientist, SickKids Hospital, Gary Piazza, Department Head, Drug Discovery and Development, Auburn University, Jean-Phillipe, Pellois Professor, Texas A and M University